Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma

NCT01453504 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: DHAP
DRUG: Everolimus

Sponsor

University of Cologne